Business Description
Rezolute is a clinical-stage medical company working to help patients who suffer from dangerously low blood sugar caused by the body producing too much insulin. The company's primary treatment, ersodetug, is a drug delivered through an IV that is currently being tested in advanced clinical trials for children born with a rare genetic condition that causes this problem, as well as for adults whose tumors trigger excess insulin production. Founded in 2010 and based in Redwood City, California, the company was previously called AntriaBio before adopting its current name in 2017.
